Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration
Authors
Keywords
Hepatocellular carcinoma, Monocarboxylate transporter 4, Prognostic value, Molecular mechanism, Cell proliferation and metastasis
Journal
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
Volume 141, Issue 7, Pages 1151-1162
Publisher
Springer Nature
Online
2014-12-03
DOI
10.1007/s00432-014-1888-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2015) et al. JOURNAL OF HEPATOLOGY
- Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma
- (2014) Akinobu Ohno et al. LIVER INTERNATIONAL
- Monocarboxylate Transporter 4 Facilitates Cell Proliferation and Migration and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma Patients
- (2014) Jiang Zhu et al. PLoS One
- Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer
- (2013) Michael P Lisanti et al. CELL CYCLE
- Cancer metabolism, stemness and tumor recurrence
- (2013) Joseph M. Curry et al. CELL CYCLE
- A Hepatocellular Carcinoma 5-Gene Score Associated With Survival of Patients After Liver Resection
- (2013) Jean–Charles Nault et al. GASTROENTEROLOGY
- SUOX is a promising diagnostic and prognostic biomarker for hepatocellular carcinoma
- (2013) Guang-Zhi Jin et al. JOURNAL OF HEPATOLOGY
- Inhibition of monocarboxylate transporter-4 depletes stem-like glioblastoma cells and inhibits HIF transcriptional response in a lactate-independent manner
- (2013) K S Lim et al. ONCOGENE
- Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
- (2012) Mary Maluccio et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Recent agents targeting HIF-1α for cancer therapy
- (2012) Yaozhong Hu et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Prognostic value of the 7th edition of the AJCC staging system as a clinical staging system in patients with hepatocellular carcinoma
- (2011) Yoon Hee Chun et al. EUROPEAN JOURNAL OF CANCER
- Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular Carcinoma
- (2011) Augusto Villanueva et al. GASTROENTEROLOGY
- Differences in metabolism between adeno- and squamous cell non-small cell lung carcinomas: Spatial distribution and prognostic value of GLUT1 and MCT4
- (2011) Tineke W.H. Meijer et al. LUNG CANCER
- CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors
- (2011) R. Le Floch et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Tumor Cell Metabolism: Cancer's Achilles' Heel
- (2008) Guido Kroemer et al. CANCER CELL
- EpCAM and -Fetoprotein Expression Defines Novel Prognostic Subtypes of Hepatocellular Carcinoma
- (2008) T. Yamashita et al. CANCER RESEARCH
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started